[Latin Name] Trifolium pratensis L.

[Specification] Total isoflavones 20%; 40%; 60% HPLC

[Appearance] Brown to tan fine powder

Plant Part Used: Whole herb

[Particle size] 80Mesh

[Loss on drying] ≤5.0%

[Heavy Metal] ≤10PPM

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Shelf life] 24 Months

[Package] Packed in paper-drums and two plastic-bags inside.

[Net weight] 25kgs/drum

[What is Red Clober]

Red clover is a member of the legume family – the same class of plants where we find chickpeas and soybeans. Red clover extracts are used as dietary supplements for their high content of isoflavone compounds – which possess weak estrogenic activity and have been associated with a variety of health benefits during menopause (reduction of hot flashes, promotion of heart health and maintenance of bone density).

[Function]

1. Red Clover Extract can Improving health, anti-spasm, known for healing properties.

2. Red Clover Extract can Treating the skin diseases (such as eczema, burns, ulcers, psoriasis),

3. Red Clover Extract can Treating respiratory discomfort (such as asthma, bronchitis, intermittent cough)

4. Red Clover Extract can Owning anti-cancer activity and prevention of prostate disease.

5. Red Clover Extract can Most valuable of its estrogen-like effect and alleviate breast pain suffering.

6. Red Clover Extract can Contained red clover isoflavones plays in a weak estrogen, estrogen reduces the number and thusalleviate the suffering.

7. Red Clover Extract can Maintaining bone mineral density in postmenopausal women

8. Red Clover Extract can Raising high density lipoprotein cholesterol.

Functional dynamics of the gut microbiome in health and disease

Air date: Tuesday, October 27, 2015, 3:00:00 PM

Category: WALS – Wednesday Afternoon Lectures

Runtime: 01:00:59

Description: NIH Director’s Wednesday Afternoon Lecture Series

Dr. Fraser’s current research interests are focused oncharacterization of the structure and function of the microbial communitiesthat are found in the human environment, as part of the NIH-funded HumanMicrobiome Project, including projects specifically focused on obesity,metabolic syndrome, inflammatory bowel disease, the interactions between thehuman immune response and the gut microbiome, and the impact of probiotics onthe structure and function of the intestinal microbiome.

About the annual Rolla E. Dyer lecture:

The annual Rolla E. Dyer Lecture features aninternationally renowned researcher who has contributed substantially to themedical as well as the biological knowledge of infectious diseases. Establishedin 1950, the lecture series honors former NIH director Dr. Dyer, who was anoted authority on infectious diseases.

For more information go to https://oir.nih.gov/wals

Author: Claire Fraser, Ph.D., Professor of Medicine, Microbiology and Immunology; Director, Institute for Genome Sciences; University of Maryland School of Medicine

Permanent link: https://videocast.nih.gov/launch.asp?19272

Poly-N-acetyl glucosamine (PNAG) is a broadly expressed surface or capsular polysaccharide detected on major bacterial and eukaryotic pathogens. Natural antibody to PNAG is generally poorly effective at mediating protection against infection, but by using modified glycoforms of the antigen antibodies can be elicited or selected from libraries that have the ability to kill target organisms facilitated by activation of the classical pathway of complement. Protective efficacy has been validated in a broad range of mouse systems of infection with different organisms and in pigs challenged with Actinobacillus pleuropneumoniae. The unexpected discovery by multiple investigators of a highly conserved surface antigen on most major pathogens, and means to engender effective immunity, opens up the potential for a single vaccine to provide partial or perhaps complete protection against many of the major infectious agents relevant to animal and human health.